Organon & Co. (OGN)
13.34
+0.02
(+0.15%)
USD |
NYSE |
Apr 29, 16:00
13.32
-0.02
(-0.15%)
After-Hours: 20:00
Organon Market Cap : 3.473B for April 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 274.31B |
| Abbott Laboratories | 158.70B |
| Gilead Sciences, Inc. | 159.94B |
| Replimune Group, Inc. | 196.52M |
| Hims & Hers Health, Inc. | 6.002B |
Market Cap Related Metrics
| PE Ratio | 18.62 |
| PS Ratio | 0.559 |
| Price to Book Value | 4.618 |
| Price to Free Cash Flow | 6.841 |
| Price | 13.34 |
| Earnings Yield | 5.37% |
| Operating PE Ratio | 2.793 |
| Normalized PE Ratio | 8.023 |